Nicholas S. Downing, Audrey D. Zhang, Joseph S. Ross
Abstract
Between 2011 and 2015, the Food and Drug Administration (FDA) approved 170 new therapeutic agents, and the European Medicines Agency (EMA) approved 144. The times for those regulatory reviews were, on average, 60 days shorter at the FDA than at the EMA.
OpenAlex reports 61 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Between 2011 and 2015, the Food and Drug Administration (FDA) approved 170 new therapeutic agents, and the European Medicines Agency (EMA) approved 144. The times for those regulatory reviews were, on average, 60 days shorter at the FDA than at the EMA.
Key concepts: Medicine, Food and drug administration, Drug approval, Drug, Pharmacology, Regulatory agency, Agency (philosophy), Approved drug